JPRN-UMIN000043768
Recruiting
未知
A prospective observational study on efficacy and relapse prevention markers in repetitive transcranial magnetic stimulation therapy for depression - A prospective observational study on efficacy and relapse prevention markers in repetitive transcranial magnetic stimulation therapy for depression
Department of Neuropsychiatry, Wakayama Medical University0 sites60 target enrollmentMarch 29, 2021
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Neuropsychiatry, Wakayama Medical University
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Implanted electronic devices/magnetic material Claustrophobia Subjects who are judged as unsuitable for participation in this study by medical doctor
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
To Study the Efficacy of Directly Acting Antivirals In Patients of Hepatitis C Infection who are On Dialysis.Health Condition 1: null- Chronic Kideny Disease Patients on Hemodialysis With Hepatitis C infectionHealth Condition 2: N186- End stage renal diseaseCTRI/2018/06/014408INDRAPRASTHA APOLLO HOSPITA34
Recruiting
Not Applicable
Prospective observation study for the efficacy and safety of combined therapy with Ipilimumab and Nivolumab in non-small cell lung cancer patientson small cell lung cancerJPRN-UMIN000044811Kyoto Prefectural University of Medicine50
Recruiting
Not Applicable
A prospective observational study on the efficacy of switching to sertraline in depressive patients who failed treatment with duloxetinemajor depressive disorderJPRN-UMIN000009609Tokyo Womens Medical University100
Not yet recruiting
Not Applicable
Study of effectiveness and side effects of light therapy with oral medication called Khellin in Vitiligo patients.CTRI/2020/02/023495Dr Lavin Bhatia
Recruiting
Not Applicable
The efficacy and safety of the Gefapixant in patients with interstitial lung diseaseinterstitial lung diseaseJPRN-jRCT1031220275Abe Mitsuhiro30